Progress in the treatment of elderly patients with primary membranous nephropathy
10.3760/cma.j.issn.0254-9026.2021.10.003
- VernacularTitle:老年人膜性肾病临床诊治的进展
- Author:
Yun BO
1
;
Xiaohua PEI
;
Weihong ZHAO
Author Information
1. 南京医科大学第一附属医院老年肾科 210029
- Keywords:
Glomerulonephritis, membranous;
Phospholipases A2
- From:
Chinese Journal of Geriatrics
2021;40(10):1234-1237
- CountryChina
- Language:Chinese
-
Abstract:
Membranous nephropathy(MN)is the most common cause of nephrotic syndrome in the elderly.In recent years, the prevalence of MN has been increasing every year.The diagnosis and treatment of MN has entered the new era of molecular medicine with the identification of autoantibodies against the phospholipase A2 receptor(PLA2R). This review focuses on recent advances in the treatment and diagnosis of MN based on the 2020 Kidney Disease: Improving Global Outcomes(KDIGO)guidelines.
